SCOPUS 정보 검색 플랫폼

Current Medical Research and Opinion

Volumn 26, Issue 9, 2010, Pages 2237-2242

Assessment of new application system in Portuguese patients with relapsing-remitting multiple sclerosis

(3) De Sa J a Urbano, G b Reis, L c

a HOSPITAL DE SANTA MARIA (Portugal)

b Bayer Schering Pharma AG (Portugal)

c BAYER PHARMA AG (Germany)

Author keywords

Adherence to medication; Application system; Interferon beta 1b; Patient compliance; Relapsing remitting multiple sclerosis; Survey

Indexed keywords

GLATIRAMER; INTERFERON BETA SERINE;

ADULT; ARTICLE; DESCRIPTIVE RESEARCH; DRUG DELIVERY SYSTEM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PATIENT SATISFACTION; PORTUGAL; QUESTIONNAIRE; RETROSPECTIVE STUDY;

ADJUVANTS, IMMUNOLOGIC; ADULT; ALGORITHMS; DATA COLLECTION; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; INJECTIONS, JET; INTERFERON-BETA; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PATIENT SATISFACTION; PORTUGAL; RETROSPECTIVE STUDIES;

EID: 77955612069 PISSN: 03007995 EISSN: 14734877 Source Type: Journal
DOI: 10.1185/03007995.2010.508688 Document Type: Article

Times cited : (9)

References (11)

1
- 61949261269
- Management strategies for improving the tolerability of interferons in the treatment of multiple sclerosis
- Girouard N, Theoret G. Management strategies for improving the tolerability of interferons in the treatment of multiple sclerosis. Can J Neurosci Nurs 2008;30:18-25
- (2008) Can J Neurosci Nurs , vol.30 , pp. 18-25
- Girouard, N.¹ Theoret, G.²

2
- 55649105874
- A novel needle for subcutaneous injection of interferon beta-1a: Effect on pain in volunteers and satisfaction in patients with multiple sclerosis
- Jaber A, Bozzato GB, Vedrine L, et al. A novel needle for subcutaneous injection of interferon beta-1a: effect on pain in volunteers and satisfaction in patients with multiple sclerosis. BMC Neurol 2008;8:38
- (2008) BMC Neurol , vol.8 , pp. 38
- Jaber, A.¹ Bozzato, G.B.² Vedrine, L.³

3
- 0346586802
- Tolerability of interferon beta-1b (Betaferon/Betaseron) can be significantly improved using both interferon-free needle and automated injection techniques
- Tornatore C, Bartlett D. Tolerability of interferon beta-1b (Betaferon/Betaseron) can be significantly improved using both interferon-free needle and automated injection techniques. J Neurol 2002;249(Suppl 1):814
- (2002) J Neurol , vol.249 , Issue.SUPPL. 1 , pp. 814
- Tornatore, C.¹ Bartlett, D.²

4
- 33745904768
- Reduction of injection site reactions in multiple sclerosis (MS) patients newly started on interferon beta 1b therapy with two different devices
- Brochet B, Lemaire G, Beddiaf A. Reduction of injection site reactions in multiple sclerosis (MS) patients newly started on interferon beta 1b therapy with two different devices. Rev Neurol (Paris) 2006;162:735-740
- (2006) Rev Neurol (Paris) , vol.162 , pp. 735-740
- Brochet, B.¹ Lemaire, G.² Beddiaf, A.³

5
- 15944398345
- Interferon-beta1b for multiple sclerosis
- Burks J. Interferon-beta1b for multiple sclerosis. Expert Rev Neurother 2005;5:153-164
- (2005) Expert Rev Neurother , vol.5 , pp. 153-164
- Burks, J.¹

6
- 39549087978
- Comparison of injection site pain and injection site reactions in relapsing-remitting multiple sclerosis patients treated with interferon beta-1a or 1b
- Baum K, O'Leary C, Coret Ferrer F, et al. Comparison of injection site pain and injection site reactions in relapsing-remitting multiple sclerosis patients treated with interferon beta-1a or 1b. Mult Scler 2007;13:1153-1160
- (2007) Mult Scler , vol.13 , pp. 1153-1160
- Baum, K.¹ O'Leary, C.² Coret Ferrer, F.³

7
- 77955593078
- Assessment of Betaferon®Application Systems in Portugal: Patients' Feedback [Poster] Washington, Washington DC, USA
- Bugge J-P, Reis L. Assessment of Betaferon®Application Systems in Portugal: Patients' Feedback [Poster]. 2007 Consortium of Multiple Sclerosis Centres Annual Meeting, Washington, Washington DC, USA, 2007
- (2007) 2007 Consortium of Multiple Sclerosis Centres Annual Meeting
- Bugge, J.-P.¹ Reis, L.²

8
- 75749104707
- Needles: A comparison study
- 32-34
- Mayer G, Knappertz V, Kinast P. Needles: a comparison study. Med Device Technol 2009;20:30, 32-34
- (2009) Med Device Technol , vol.20 , pp. 30
- Mayer, G.¹ Knappertz, V.² Kinast, P.³

9
- 64249093467
- A review of disease-modifying therapies for MS: Maximizing adherence and minimizing adverse events
- Brandes DW, Callender T, Lathi E, et al. A review of disease-modifying therapies for MS: maximizing adherence and minimizing adverse events. Curr Med Res Opin 2009;25:77-92
- (2009) Curr Med Res Opin , vol.25 , pp. 77-92
- Brandes, D.W.¹ Callender, T.² Lathi, E.³

10
- 77955614051
- Factors that influence adherence with disease-modifying therapy in multiple sclerosis [P01.071]
- Presented at April 1-8, San Diego, CA
- Treadaway K, Hawker K, Racke M, et al. Factors that influence adherence with disease-modifying therapy in multiple sclerosis [P01.071]. Presented at: 58th Annual Meeting of the American Academy of Neurology, April 1-8, San Diego, CA, 2006
- (2006) 58th Annual Meeting of the American Academy of Neurology
- Treadaway, K.¹ Hawker, K.² Racke, M.³

11
- 61549098704
- Early interferon beta treatment in multiple sclerosis: Nursing care implications of the BENEFIT study
- Webb UH. Early interferon beta treatment in multiple sclerosis: nursing care implications of the BENEFIT study. J Neurosci Nurs 2008;40:356-361
- (2008) J Neurosci Nurs , vol.40 , pp. 356-361
- Webb, U.H.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.